Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
335
-
Total 13F shares, excl. options
-
47.2M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$5.16B
-
Value change
-
+$108M
-
Put/Call ratio
-
0.35
-
Number of buys
-
154
-
Number of sells
-
-158
-
Price
-
$109.45
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q4 2017
391 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q4 2017.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 335 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.2M shares
of 50.5M outstanding shares and own 93.5% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (5.06M shares), BlackRock Inc. (4.03M shares), FMR LLC (3M shares), AQR CAPITAL MANAGEMENT LLC (1.52M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.41M shares), RENAISSANCE TECHNOLOGIES LLC (1.4M shares), ARIEL INVESTMENTS, LLC (1.35M shares), STATE STREET CORP (1.3M shares), MACKENZIE FINANCIAL CORP (1.07M shares), and GOLDMAN SACHS GROUP INC (1.01M shares).
This table shows the top 335 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.